Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4591)
All Articles published online
|
Mar 28, 2012 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Geng M, Cao YC, Chen YJ, Jiang H, Bi LQ, Liu XH. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. World J Gastroenterol 2012; 18(12): 1328-1338 [PMID: 22493546 DOI: 10.3748/wjg.v18.i12.1328] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i12/1328.htm |
| Number | Citing Articles |
| 1 |
Xuedi Zheng, Mengyuan Li, Qi Chen, Boli Ma, Xueyi Nie, Yueyang Liu, Yi Yang, Jinrui Xu, Yujiong Wang. Ror2-mediated cholesterol accumulation regulates autophagic activity within BCG-infected macrophages. Microbial Pathogenesis 2022; 167: 105564 doi: 10.1016/j.micpath.2022.105564
|
| 2 |
Lishan Song, Chaojie Xu, Tong Zhang, Shengyang Chen, Shuiquan Hu, Bingbing Cheng, Hao Tong, Xiaoyong Li. Clinical neutrophil-associated genes as reliable predictors of hepatocellular carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.989779
|
| 3 |
Song-Zhu Yang, Jian-Tao Wang, Wei-Wei Yu, Qing Liu, Yan-Fang Wu, Shu-Guang Chen. Downregulation of <italic>KIF1B</italic> mRNA in hepatocellular carcinoma tissues correlates with poor prognosis. World Journal of Gastroenterology 2015; 21(27): 8418-8424 doi: 10.3748/wjg.v21.i27.8418
|
| 4 |
Hongbin Zhang, Ke Xu, Qin Xiang, Lijuan Zhao, Benxu Tan, Ping Ju, Xiufu Lan, Yi Liu, Jian Zhang, Zheng Fu, Chao Li, Jinzhi Wang, Jixiang Song, Yun Xiao, Zhaobo Cheng, Yan Wang, Shu Zhang, Tingxiu Xiang. LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma. Genes & Diseases 2022; 9(1): 151 doi: 10.1016/j.gendis.2020.07.007
|
| 5 |
Daoqi Zhu, Zhulin Yang, Ziru Liu, Qiong Zou, Yuan Yuan, Chunhong Hu. Association between Wnt inhibitory factor 1 and receptor tyrosine kinase-like orphan receptor 2 protein expression and the clinical pathological significance in benign and malignant pancreatic lesions. Oncology Letters 2017; 13(4): 2244 doi: 10.3892/ol.2017.5704
|
| 6 |
L. He, Z. Yang, J. Zhou, W. Wang. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors. Clinical and Translational Oncology 2015; 17(6): 438 doi: 10.1007/s12094-014-1254-y
|
| 7 |
Jing Yang, Antonella Cusimano, Jappmann K. Monga, Morgan E. Preziosi, Filippo Pullara, Guillermo Calero, Richard Lang, Terry P. Yamaguchi, Kari N. Nejak-Bowen, Satdarshan P. Monga. WNT5A Inhibits Hepatocyte Proliferation and Concludes β-Catenin Signaling in Liver Regeneration. The American Journal of Pathology 2015; 185(8): 2194 doi: 10.1016/j.ajpath.2015.04.021
|
| 8 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_166-1
|
| 9 |
Hui He, Gang Wu, Haiyang Liu, Ying Cheng, Yanqiu Yu, Yawei Wang, Yongfeng Liu. Low RIN1 Expression in HCC Is Associated With Tumor Invasion and Unfavorable Prognosis. American Journal of Clinical Pathology 2013; 140(1): 73 doi: 10.1309/AJCPEGWYDD86WWJK
|
| 10 |
JIANJUN HUANG, YING SHI, HUI LI, DUNYONG TAN, MEISONGZHU YANG, XIANG WU. Knockdown of receptor tyrosine kinase-like orphan receptor 2 inhibits cell proliferation and colony formation in osteosarcoma cells by inducing arrest in cell cycle progression. Oncology Letters 2015; 10(6): 3705 doi: 10.3892/ol.2015.3797
|
| 11 |
Dongli Liu, Kate Gunther, Luis A. Enriquez, Benjamin Daniels, Tracy A. O’Mara, Katrina Tang, Amanda B. Spurdle, Caroline E. Ford. ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-70924-z
|
| 12 |
Rui Li, Tianfeng Liu, Juanjuan Shi, Wenqing Luan, Xuan Wei, Jiangtao Yu, Hongluan Mao, Peishu Liu. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-02178-x
|
| 13 |
Yagmur Azbazdar, Mustafa Karabicici, Esra Erdal, Gunes Ozhan. Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.631623
|
| 14 |
Li Wang, Min Yao, Miao Fang, Wen-Jie Zheng, Zhi-Zhen Dong, Liu-Hong Pan, Hai-Jian Zhang, Deng-Fu Yao. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2018; 17(3): 227 doi: 10.1016/j.hbpd.2018.03.005
|
| 15 |
Seung Eun Lee, So Dug Lim, So Young Kang, Sang Bum Suh, Yeon‐Lim Suh. Prognostic Significance of Ror2 and Wnt5a Expression in Medulloblastoma. Brain Pathology 2013; 23(4): 445 doi: 10.1111/bpa.12017
|
| 16 |
Jie Mao, Duowei Wang, Zhuo Wang, Wei Tian, Xianjing Li, Jingjing Duan, Yun Wang, Hongbao Yang, Linjun You, Yan Cheng, Jinsong Bian, Zhen Chen, Yong Yang. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway. Cancer Letters 2016; 380(1): 134 doi: 10.1016/j.canlet.2016.06.020
|
| 17 |
Zufan Debebe, W. Kimryn Rathmell. Ror2 as a Therapeutic Target in Cancer. Pharmacology & Therapeutics 2015; 150: 143 doi: 10.1016/j.pharmthera.2015.01.010
|
| 18 |
Gangli Liu, Maria A. Kukuruzinska, Xin Xu. Ror2 may be downregulated in oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2013; 116(1): 120 doi: 10.1016/j.oooo.2012.12.018
|
| 19 |
Muhammad Sohaib Khan, Hee-Sun Kim, Ranhee Kim, Sang Ho Yoon, Sang Geon Kim. Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome. International Journal of Molecular Sciences 2023; 24(8): 7454 doi: 10.3390/ijms24087454
|
| 20 |
Xiang Hu, Chenjie Zhou, Guolin He, Yuan Cheng, Mingxin Pan, Yi Gao. Inhibition of Frizzled-2 by small interfering RNA protects rat hepatic BRL-3A cells against cytotoxicity and apoptosis induced by Hypoxia/Reoxygenation. Gastroenterología y Hepatología (English Edition) 2020; 43(3): 107 doi: 10.1016/j.gastre.2019.02.034
|
| 21 |
Jiang Chen, Jinghua Liu, Renan Jin, Jiliang Shen, Yuelong Liang, Rui Ma, Hui Lin, Xiao Liang, Hong Yu, Xiujun Cai, Andreas Krieg. Cytoplasmic and/or Nuclear Expression of β-Catenin Correlate with Poor Prognosis and Unfavorable Clinicopathological Factors in Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE 2014; 9(11): e111885 doi: 10.1371/journal.pone.0111885
|
| 22 |
Mune Sanada, Masaya Yamazaki, Tatsuya Yamada, Kosuke Fujino, Shinji Kudoh, Yuki Tenjin, Haruki Saito, Noritaka Kudo, Younosuke Sato, Akira Matsuo, Makoto Suzuki, Takaaki Ito. Heterogeneous expression and role of receptor tyrosine kinase-like orphan receptor 2 (ROR2) in small cell lung cancer. Human Cell 2022; 36(1): 409 doi: 10.1007/s13577-022-00830-1
|
| 23 |
Jennifer E. Kung, Natalia Jura. Prospects for pharmacological targeting of pseudokinases. Nature Reviews Drug Discovery 2019; doi: 10.1038/s41573-019-0018-3
|
| 24 |
Bing Cui, Suping Zhang, Liguang Chen, Jianqiang Yu, George F. Widhopf, Jessie-F. Fecteau, Laura Z. Rassenti, Thomas J. Kipps. Targeting ROR1 Inhibits Epithelial–Mesenchymal Transition and Metastasis. Cancer Research 2013; 73(12): 3649 doi: 10.1158/0008-5472.CAN-12-3832
|
| 25 |
Edgar S Wills, Wybrich R Cnossen, Joris A Veltman, Rob Woestenenk, Marloes Steehouwer, Jody Salomon, René H M te Morsche, Meritxell Huch, Jayne Y Hehir-Kwa, Martijn J Banning, Rolph Pfundt, Ronald Roepman, Alexander Hoischen, Joost P H Drenth. Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes. European Journal of Human Genetics 2016; 24(12): 1707 doi: 10.1038/ejhg.2016.97
|
| 26 |
Mohan Krishna Ghanta, Mohammad Faiz Hussain, Asmita Karnalkar, Sirpu Natesh Nagabhishek, Poojith Nuthalapati, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 401 doi: 10.1016/B978-0-323-99283-1.00003-3
|
| 27 |
Xiao-Hong Liu. Molecular Mechanism of HBx Protein Function in HBv Related Hepatocellular Carcinoma Carcinogenesis. Gastroenterology & Hepatology: Open Access 2016; 5(2) doi: 10.15406/ghoa.2016.05.00135
|
| 28 |
Stefanie Thiele, Ariane Zimmer, Andy Göbel, Tilman D. Rachner, Sandra Rother, Susanne Fuessel, Michael Froehner, Manfred P. Wirth, Michael H. Muders, Gustavo B. Baretton, Franz Jakob, Martina Rauner, Lorenz C. Hofbauer. Role of WNT5A receptors FZD5 and RYK in prostate cancer cells. Oncotarget 2018; 9(43): 27293 doi: 10.18632/oncotarget.25551
|
| 29 |
Chenlin Lu, Xudong Wang, Huijun Zhu, Jian Feng, Songshi Ni, Jianfei Huang. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer. Oncotarget 2015; 6(28): 24912 doi: 10.18632/oncotarget.4701
|
| 30 |
Anna Gajos-Michniewicz, Malgorzata Czyz. WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities. Genes & Diseases 2024; 11(2): 727 doi: 10.1016/j.gendis.2023.02.050
|
| 31 |
Muhong Guo, Ge Ma, Xiaolan Zhang, Weiwei Tang, Junfeng Shi, Qian Wang, Ye Cheng, Bin Zhang, Jin Xu. ROR2 knockdown suppresses breast cancer growth through PI3K/ATK signaling. Aging 2020; 12(13): 13115 doi: 10.18632/aging.103400
|
| 32 |
Ida Sola, Valentina Karin‑Kujundzic, Frane Paic, Lada Lijovic, Mislav Glibo, Nikola Serman, Tihana Duic, Anita Skrtic, Krunoslav Kuna, Semir Vranic, Ljiljana Serman. WNT5A, β‑catenin and SUFU expression patterns, and the significance of microRNA deregulation in placentas with intrauterine growth restriction. Molecular Medicine Reports 2022; 27(2) doi: 10.3892/mmr.2022.12914
|
| 33 |
Mahdieh Razmi, Fatemeh Tajik, Farideh Hashemi, Ayna Yazdanpanah, Fatemeh Hashemi-Niasari, Adeleh Divsalar. The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach. Journal of Gastrointestinal Cancer 2024; doi: 10.1007/s12029-024-01022-w
|
| 34 |
Caroline E. Ford, Sean Si Qian Ma, Ashfaque Quadir, Robyn L. Ward. The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis. International Journal of Cancer 2013; 133(4): 779 doi: 10.1002/ijc.27984
|
| 35 |
Xiang Hu, Chenjie Zhou, Guolin He, Yuan Cheng, Mingxin Pan, Yi Gao. Inhibition of Frizzled-2 by small interfering RNA protects rat hepatic BRL-3A cells against cytotoxicity and apoptosis induced by Hypoxia/Reoxygenation. Gastroenterología y Hepatología 2020; 43(3): 107 doi: 10.1016/j.gastrohep.2019.02.006
|
| 36 |
Zhan Zhang, Xiaofang Wang, Linlin Zhang, Ying Shi, Jinming Wang, Huan Yan. Wnt/β-catenin signaling pathway in trophoblasts and abnormal activation in preeclampsia. Molecular Medicine Reports 2017; 16(2): 1007 doi: 10.3892/mmr.2017.6718
|
| 37 |
Rukkumani Rajagopalan, Jatinder V. Yakhmi. Nanostructures for Cancer Therapy. 2017; : 211 doi: 10.1016/B978-0-323-46144-3.00008-8
|
| 38 |
Ramy R. Saleh, Jesús Fuentes Antrás, Paloma Peinado, Pedro Pérez-Segura, Atanasio Pandiella, Eitan Amir, Alberto Ocaña. Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis. Cancer Treatment Reviews 2019; 77: 11 doi: 10.1016/j.ctrv.2019.05.006
|
| 39 |
Cheng-Fa Yeh, Ti-Chun Chan, Hung-Lung Ke, Tzu-Ju Chen, Li-Ching Wu, Hsiang-Ying Lee, Yu-Ching Wei, Wen-Jeng Wu, Chien-Feng Li, Wei-Ming Li. Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma. Biomedicines 2021; 9(8): 1054 doi: 10.3390/biomedicines9081054
|
| 40 |
Weihua Li, Man Li, Dongjiang Liao, Xinpeng Lu, Xia Gu, Qianqian Zhang, Zhixiang Zhang, Hui Li. Carboxyl-terminal truncated HBx contributes to invasion and metastasis via deregulating metastasis suppressors in hepatocellular carcinoma. Oncotarget 2016; 7(34): 55110 doi: 10.18632/oncotarget.10399
|
| 41 |
Xuying Zhang, Hermann H. Swalve, René Pijl, Frank Rosner, Monika Wensch-Dorendorf, Bertram Brenig. Interdigital Hyperplasia in Holstein Cattle Is Associated With a Missense Mutation in the Signal Peptide Region of the Tyrosine-Protein Kinase Transmembrane Receptor Gene. Frontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.01157
|
| 42 |
Mingde Huang, Yun Pan, Jibin Liu, Fuzhen Qi, Juan Wen, Kaipeng Xie, Hongxia Ma, Hongbing Shen, Yao Liu, Juncheng Dai. A genetic variant at KIF1B predicts clinical outcome of HBV-related hepatocellular carcinoma in Chinese. Cancer Epidemiology 2014; 38(5): 608 doi: 10.1016/j.canep.2014.07.012
|
| 43 |
Sean S.Q. Ma, Claire E. Henry, Estelle Llamosas, Rupert Higgins, Benjamin Daniels, Luke B. Hesson, Nicholas J. Hawkins, Robyn L. Ward, Caroline E. Ford. Validation of specificity of antibodies for immunohistochemistry: the case of ROR2. Virchows Archiv 2017; 470(1): 99 doi: 10.1007/s00428-016-2019-5
|
| 44 |
Ming Geng, Xuan Xin, Li-Quan Bi, Lu-Ting Zhou, Xiao-Hong Liu. Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis. World Journal of Gastroenterology 2015; 21(38): 10732-10738 doi: 10.3748/wjg.v21.i38.10732
|
| 45 |
Himani Vaidya, Candie Rumph, Karen S. Katula, Javier S Castresana. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2. PLOS ONE 2016; 11(3): e0151392 doi: 10.1371/journal.pone.0151392
|
| 46 |
María Victoria Castro, Pablo Lopez-Bergami. Cellular and molecular mechanisms implicated in the dual role of ROR2 in cancer. Critical Reviews in Oncology/Hematology 2022; 170: 103595 doi: 10.1016/j.critrevonc.2022.103595
|
| 47 |
Ying Xu, Yan-Hui Ma, Ying-Xin Pang, Zhe Zhao, Jing-Jing Lu, Hong-Luan Mao, Pei-Shu Liu. Ectopic repression of receptor tyrosine kinase–like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial–mesenchymal transition. Tumor Biology 2017; 39(5): 101042831770162 doi: 10.1177/1010428317701627
|
| 48 |
Likun Yan, Qingguo Du, Jianfeng Yao, Ruiting Liu. ROR2 inhibits the proliferation of gastric carcinoma cells via activation of non-canonical Wnt signaling. Experimental and Therapeutic Medicine 2016; 12(6): 4128 doi: 10.3892/etm.2016.3883
|
| 49 |
Lili Li, Jianming Ying, Xin Tong, Lan Zhong, Xianwei Su, Tingxiu Xiang, Xingsheng Shu, Rong Rong, Lei Xiong, Hongyu Li, Anthony T. C. Chan, Richard F. Ambinder, Yajun Guo, Qian Tao. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas. Cellular and Molecular Life Sciences 2014; 71(11): 2179 doi: 10.1007/s00018-013-1485-z
|
| 50 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2987 doi: 10.1007/978-3-319-26956-6_166
|
| 51 |
Wei Zhang, Yongbing Yan, Miao Gu, Xudong Wang, Huijun Zhu, Shu Zhang, Wei Wang. High expression levels of Wnt5a and Ror2 in laryngeal squamous cell carcinoma are associated with poor prognosis. Oncology Letters 2017; 14(2): 2232 doi: 10.3892/ol.2017.6386
|
| 52 |
Kazuki Wakizaka, Toshiya Kamiyama, Tatsuhiko Kakisaka, Tatsuya Orimo, Akihisa Nagatsu, Takeshi Aiyama, Shunsuke Shichi, Akinobu Taketomi. Expression of Wnt5a and ROR2, Components of the Noncanonical Wnt-Signaling Pathway, is Associated with Tumor Differentiation in Hepatocellular Carcinoma. Annals of Surgical Oncology 2024; 31(1): 262 doi: 10.1245/s10434-023-14402-6
|